Pharmaceutical Excipients Market to Attain $20.22 Billion by 2034, Unveiled in Latest Report, Showing a 6.6% CAGR

Pharmaceutical Excipients Market

Pharmaceutical Excipients-Market Insights, Size, Revenue, Outlook, Overview, and Analysis. The pharmaceutical excipients market size was valued at USD 10.70 billion in 2024. It is projected to grow to USD 20.22 billion by 2034, exhibiting a CAGR of 6.6% during 2025-2034.

Report Scope

This comprehensive study provides an accurate overview of the global market. In-depth analyses of sales volume, price, revenue, market share, and important companies are included. The market is further divided into segments by product, formulation, functionality, and region in the study, which offers a comprehensive picture of the state of the market.

Request For a Sample with An Exclusive Look at the Latest Trends and Upcoming Advancements:
https://www.polarismarketresearch.com/industry-analysis/pharmaceutical-excipients-market/request-for-sample

Market Definition

Pharmaceutical excipients refer to inactive substances formulated alongside the active pharmaceutical ingredient (API) in a drug product. These excipients don't posses any therapeutic or direct pharmacological action, but they play a crucial role in the effectiveness, safety, and stability of pharmaceutical products. They serve various functions such as aiding in the manufacturing process, enhancing the stability of the active ingredient, and improving the drug's bioavailability. In addition, they ensure the desired drug release profile and help make the medication more palatable and acceptable to patients by improving texture, appearance, and taste. There are various types of excipients, each serving a specific role.

Market Drivers

• Rising Investments in Pharmaceutical Manufacturing: Companies globally are making substantial investments in expanding their manufacturing facilities. For instance, in February 2025, Eli Lilly announced an investment of USD 27 billion for the establishment of four manufacturing mega-sites in the US. Such investments are fueling the need for pharmaceutical excipients in drug manufacturing to improve bioavailability and patient acceptability.

• Regulatory Reforms Enhancing Clinical Trial Processes: Improved regulatory reforms are supporting the streamlining of regulatory processes and providing incentives to attract more trails. These shifts are anticipated to drive pharmaceutical R&D activities.

Need More Information? Inquire more about this report before purchase:
https://www.polarismarketresearch.com/industry-analysis/pharmaceutical-excipients-market/inquire-before-buying

Competitive Landscape

The market features several prominent companies actively playing a vital role in supplying essential excipients for pharmaceutical formulations. Some of the major market participants include:
• Archer Daniels Midland Company
• Ashland Global Holdings Inc.
• Associated British Foods plc
• BASF SE
• Colorcon, Inc.
• Croda International Plc
• DFE Pharma
• DuPont de Nemours, Inc.
• Evonik Industries AG
• JRS Pharma
• Kerry Group plc
• MEGGLE GmbH & Co. KG
• Roquette Frères
• The Lubrizol Corporation
• Wacker Chemie AG

Segmental Analysis

Polaris Market Research has segmented the pharmaceutical excipients market report based on product, formulation, and functionality:

By Product Outlook
• Inorganic Chemicals
• Organic Chemicals

By Formulation Outlook
• Tablets Formulation
• Capsules Formulation
• Parental Formulation
• Liquid Formulation
• Oral Formulation

By Functionality Outlook
• Blinders
• Fillers & Diluents
• Suspending & Viscosity agents
• Preservatives
• Flavoring Agents & Sweeteners
• Coating Agents

Browse Full Report:
https://www.polarismarketresearch.com/industry-analysis/pharmaceutical-excipients-market

Regional Overview
• By region, the report offers market insights into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
• Europe dominates the market for pharmaceutical excipients, driven by the region's stringent regulatory framework and well-established pharmaceutical industry. In addition, continuous advancements in drug formulation technologies contribute to the region's leading market position.
• Asia Pacific is experiencing rapid growth. The regional market growth is driven by expanding pharmaceutical manufacturing and increasing healthcare expenditures. The implementation of favorable government policies is also fueling the market expansion in the region.

Top Trending Reports of Polaris Market Research:

Biotechnology Market
https://www.polarismarketresearch.com/industry-analysis/biotechnology-market
E-Pharmacy Market
https://www.polarismarketresearch.com/industry-analysis/e-pharma-market
Cell Culture Market
https://www.polarismarketresearch.com/industry-analysis/cell-culture-market
Virus Filtration Market
https://www.polarismarketresearch.com/industry-analysis/virus-filtration-market
Optimizing Clinical Trial Designs with AI in Drug Discovery Market
https://www.polarismarketresearch.com/blog/optimizing-clinical-trial-designs-with-ai-in-drug-discovery-market

Contact:

Likhil G
8 The Green Ste 19824,
Dover, DE 19901,
United States
Phone: +1-929 297-9727
Email: sales@polarismarketresearch.com
Web: https://www.polarismarketresearch.com
Follow Us: LinkedIn | Twitter

About Polaris Market Research & Consulting, Inc:

Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for PMR's clientele spread across different enterprises. We at Polaris are obliged to serve PMR's diverse customer base present across the industries of healthcare, technology, semiconductors, and chemicals among various other industries present around the world. We strive to provide PMR's customers with updated information on innovative technologies, high-growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to PMR's customers.

This release was published on openPR.